Skip to Content
COVID-19 Resources
Translational Research Program (TRP)
Contact CIP
Show menu
Search this site
Last Updated: 09/03/20

Head & Neck SPOREs

SPOREs in head and neck cancer support translational research on cancers of the upper aero-digestive tract. In 2016, approximately 370,309 people in the United States were living with oral cavity and oropharyngeal cancer and 96,351 with laryngeal cancer. In 2020, it is estimated that there will be 53,260 new cases of oral cavity and oropharyngeal cancer and an estimated 10,750 deaths. For laryngeal cancer, approximately 12,370 new cases and 3,750 deaths are estimated. Known risk factors for head & neck cancer include smoking, alcohol use, and human papillomavirus (HPV) infection. The first SPOREs in head and neck cancer were established in 2002, and co-funding for this program is received by the National Institute of Dental and Craniofacial Research.